Loading data for THNR — first visit, this takes a few seconds.
Amplify Weight Loss Drug ... (THNR)
NYSEArca: THNR
· Real-Time Price · USD
27.54
+0.29 (1.06%)
At close: Aug 21, 2026, 7:21 PM
27.54
+0.00%
After-hours: 5:05 PM
Amplify Weight Loss Drug & Treatment ETF (THNR) ETF Price, Holdings & Analysis
1.06% (1D)
No data available
| Bid | 13.77 |
| Market Cap | n/a |
| AUM | 5.07M |
| NAV | 27.30 |
| Beta | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | 19.94 |
| Shares Out | n/a |
| Inception Date | May 20, 2024 |
| Ask | 41.29 |
| Volume | 5,135 |
| Avg. Volume (20D) | 2,193 |
| Open | 27.59 |
| Previous Close | 27.25 |
| Day's Range | 27.54 - 27.75 |
| 52-Week Range | 22.63 - 27.75 |
| Holdings | n/a |
| Expense Ratio | 0.59% |
About THNR
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies expected to economically benefit from weight loss drug development. The index includes pharmaceutical manufacturers, manufacturers of combination therapies and telehealth providers who provide access to Amylin agonists and analogs or GLP-1 agonists and analogs, including dual GLP-1 agonists and analogs. The fund is non-diversified.
Asset Class Equity
Ticker Symbol THNR
Inception Date May 20, 2024
Provider Amplify Etfs
Website Fund Home Page
Exchange NYSEArca
Top 10 Holdings 61.60% of assets
| Name | Symbol | Weight |
|---|---|---|
| Novo Nordisk As Adr | NVO | 9.70% |
| Eli Lilly And Co | LLY | 8.92% |
| Regeneron Pharmaceut... | REGN | 6.03% |
| Cspc Pharmaceutical ... | 1093.HK | 5.52% |
| Arrowhead Pharmaceut... | ARWR | 5.34% |
| Innovent Biologics I... | 1801.HK | 5.34% |
| Amgen Inc | AMGN | 5.25% |
| Abbvie Inc | ABBV | 5.24% |
| Roche Holding Ag Ord... | ROP.SW | 5.20% |
| Merck & Co Inc | MRK | 5.06% |
Dividends Dividend Yield 1.50%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 30, 2025 | $0.4130 | n/a |
| Dec 30, 2024 | $0.2200 | n/a |
Page 1 of 2